Madam Speaker, I am pleased to have the opportunity to speak to Bill C-10.
COVID-19 continues to be part of our lives, which we all know, and testing and screening remain important tools. They allow us to rapidly detect and isolate new cases. They support contact tracing and they help prevent community outbreaks by breaking the chain of transmission. As we have been, we continue to be committed to supporting the provinces and territories' testing strategies. These are different from jurisdiction to jurisdiction, but our job is to support.
A critical part of finishing the fight against COVID-19 is making sure that we continue to prevent outbreaks at schools and workplaces. The $2.5-billion investment to purchase and distribute rapid tests across the country that is contained in this bill would ensure the delivery of millions of rapid tests to provinces and territories and indigenous communities free of charge and continue to support screening programs through our various distribution channels. Rapid tests are safe, they are effective and they are easy to administer. They provide quick results and they will empower Canadians to make more-informed decisions to protect their health and the health of their loved ones.
As all members know, rapid tests represent only one element in the tool kit to fight this pandemic. This bill therefore represents a continuation of the kinds of measures that we have implemented and will continue to implement, measures that are based on the best public health advice and scientific evidence.
Since the start of this pandemic, Health Canada has put in place rapid, innovative and agile measures to ensure prompt access to medical devices to respond to the needs of Canadians. The department has worked closely with public health partners to ensure that applications for COVID-19 testing devices are prioritized to meet urgent public health needs. These measures have allowed Health Canada to authorize over 100 testing devices, including 10 self-tests and 27 tests that can be used in a point-of-care setting.
Health Canada is also expediting the review of all treatments for COVID-19. The department has rapidly authorized several clinical trials in Canada, including for some vaccines being developed right here in Canada, without compromising on strict standards for the safety of clinical trial participants. Clinical trial regulations allow the investigation of new drugs or new uses of drugs while affording protection to participants and requiring the proper collection and retention of outcomes.
As of February 9, 115 clinical trials for COVID-19 drugs and vaccines have been authorized in Canada. Health Canada has authorized five drugs to treat COVID-19, including Remdesivir for hospitalized people, as well Paxlovid and three biologic treatments for non-hospitalized folks who have mild or moderate COVID symptoms and are at risk of developing severe disease. The Government of Canada has procured many of these treatments and continues to engage proactively with domestic and international companies to negotiate advance purchase agreements and ensure timely access in the procurement of treatments.
As we know, vaccination is one of the most effective tools that we have to combat the pandemic, and along with the availability of rapid testing, it will play an important role in protecting our supply chains and helping us to get to a point where the pandemic is behind us. Governments have an important responsibility to protect the health and safety of their citizens. That is what we have done since day one. This responsibility becomes especially critical in the face of a public health emergency such as the one we are in right now.
Since the beginning of this pandemic, the government has committed to making decisions that are based on science and based on the advice of public health officials. The government has implemented many critical measures to protect the health and safety of Canadians, including federal public servants. As the employer of the federal public service, it is the government's role to set the conditions for those employees to be safe when they are called upon to provide those services. Last October, we implemented a policy requiring that all employees of the core public service, including the RCMP, be vaccinated. This requirement applies to all employees, whether they are working remotely or working on site. It also applies to contractors who require access to federal government work sites.
Having a fully vaccinated workforce means that not only are work sites safer, but so are the communities in which these public servants live and work. It also means better protection for Canadians who are accessing government services in person, including, in particular, the more vulnerable members of our communities.
The vaccination requirements within the transportation sector have helped to protect our transport system from the impacts of omicron by reducing the frequency and severity of the COVID-19 illness among transportation workers. As we have done throughout the pandemic, we have worked closely with our partners in the transportation sector, including industry, to implement the vaccine requirements and to ensure the overall safety of the transportation system. These partners have played an invaluable, critical role in ensuring that people, goods and services continue to move in a safe and secure manner. Transportation workers have done their part by getting vaccinated and helping us all get through this pandemic.
I want to reiterate that the Government of Canada's top priority is the health and safety of all Canadians. To protect Canadians, the government has taken every measure at its disposal to protect citizens. I know that it has not been easy. The pandemic has had an undeniable impact on Canadian businesses, large and small. Canadians have been patient. They rolled up their sleeves. They did their part to protect themselves, to protect others, and they got vaccinated.
We recognize that this pandemic has created anxiety and additional stress for many Canadians. While we are all fatigued, we are also hopeful for what is to come. We are not where we were at the beginning and we can look forward to a brighter future. The measures that we have put in place, opportunities to be able to access rapid tests like the ones we are making available through this bill, will make it possible for us to look toward a bright future.